The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients’ clinical outcomes and well being while reducing healthcare systems and payors’ financial burden. NEW YORK, Feb. 12, 2025 /PRNewswire/ –…
